Get started
Work

Supplemental Figure 1 from PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

Year: 2023
Type: supplementary-materials
Abstract: Homologous recombination deficiency genomic scar assays do not predict sensitivity to PARP inhibitors in SCLC cell lines.
DOI: 10.1158/1078-0432.22467405.v1
Authors: Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger, Andy Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A. Teicher, Nadeem Riaz, Simon N. Powell, John T. Poirier, Charles M. Rudin
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361930252
Cites:
Cited by:
Related to: 10